Q22K (p.Gln22Lys) variant of RYR1 (Ryanodine receptor 1)
Q22K (p.Gln22Lys) in RYR1 (Ryanodine receptor 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
Q22K (p.Gln22Lys) variant details
- p.Gln22Lys
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.